AIOTOR Medical Twin — Molecular Research Intelligence

Molecular structures, ligand and pocket context, simulation, analysis, evidence, hypothesis and validation workflows for biomedical research and education.

AIOTOR Medical Twin showing protein structure, ligand interactions, water network, energy landscape, molecular trajectory and scientific evidence panels

MEDICAL TWIN · RESEARCH + EDUCATION

Explore molecular behavior. Build evidence. Advance research together.

Bring molecular structures, ligand and pocket context, simulation, time-linked analysis, hypotheses, validation and reproducible reporting into one connected biomedical research environment.

THE AIOTOR RESEARCH WORKSPACE

Not a protein viewer. A connected scientific investigation environment.

Move from molecular context to time-linked observation, evidence, hypothesis and validation while keeping the scientific record reviewable.

AIOTOR molecular research workspace with protein, ligand, water interactions, trajectory, energy and biological event context
Molecular structuresLigand + pocketWater interactionsEnergy + metricsEvidence historyHypotheses

AIOTOR BIOMEDICAL RESEARCH PLATFORM

Six connected capabilities. One research workflow.

Use a common workspace to move from molecular context and simulation to analysis, hypotheses, validation and a reviewable scientific record.

01 · AIOTOR MOLECULAR TWIN

Protein + molecular context

Explore structures, ligands, pockets, waters and interaction context inside the research workflow.

02 · AIOTOR SIMULATION STUDIO

Scientific experiments in motion

Configure experiments, observe evolving molecular state and retain the trajectory for comparison.

03 · TIME-LINKED ANALYSIS

Understand what changed

Compare time-linked measurements, structural changes and scientific events in context.

04 · AIOTOR HYPOTHESIS TWIN

Question → evidence → next test

Keep mechanisms, supporting evidence, conflicting observations, unknowns and next tests together.

05 · SCIENTIFIC EVIDENCE

Reproducible scientific record

Preserve experiment context, supporting evidence, reports and a reviewable research history.

06 · AIOTOR VALIDATION LAB

Validation before claims

Separate observation, simulation output, hypothesis and validated conclusions through controlled review.

ACADEMIC ACCESS · INSTITUTIONAL SUBSCRIPTION

Bring Medical Twin into teaching and research.

AIOTOR is inviting universities, medical colleges and research institutes to use Medical Twin for molecular-science education, faculty research and postgraduate projects through institutional access.

INSTITUTIONAL ACCESS

Research subscription

Provide faculty and approved learners with a shared molecular research environment for structures, simulation, analysis, hypotheses and evidence review.

  • Department or institutional access
  • Research and teaching workflows
  • Reproducible reports and exports
EDUCATION

Teach with real scientific context

Use guided molecular examples to teach structure, interactions, trajectories, RMSD, RMSF, radius of gyration, SASA, energies and scientific interpretation.

  • Faculty-led demonstrations
  • Student and postgraduate projects
  • Evidence-aware scientific learning
RESEARCH

Move from question to evidence

Keep molecular observations, analysis, hypotheses, validation results and research reports connected through the life of a project.

  • Hypothesis and next-test workflow
  • Validation and qualification work
  • Shareable scientific reporting
Interested in using Medical Twin at your institution?Tell us your department, research area and expected number of researchers or learners. We will scope institutional access with you.
Request academic subscription

SCIENTIFIC CONTINUITY

From a biomedical question to reproducible evidence.

The platform keeps molecular state, measurements, interpretation and validation connected without presenting them as the same level of scientific truth.

01QuestionDefine the biomedical problem.
02StructureEstablish molecular context.
03SimulateObserve state through time.
04AnalyzeCompare measurements and events.
05EvidencePreserve what supports the finding.
06ValidateTest, reproduce and refine.

CLINICAL RESEARCH + CRO VALIDATION COLLABORATION

Help us evaluate, validate and improve Medical Twin.

AIOTOR is inviting clinical-academic teams, hospitals, CROs and validation organizations to work with us on appropriately governed studies that test where the platform is useful, where it needs improvement and what evidence is required before any future clinical use.

TEACHING HOSPITALS + CLINICAL RESEARCHERS

Clinical-academic research

Collaborate on research questions, retrospective or prospective study design where appropriate, multidisciplinary review and evidence generation under institutional oversight.

Discuss a research study →
CROs

Validation program design

Work with AIOTOR on protocol design, endpoints, study operations, monitoring, statistical planning and reproducibility for structured validation programs.

Partner as a CRO →
VALIDATION + RESEARCH LABS

Independent evaluation

Challenge molecular, analytical and reporting workflows against appropriate reference methods, known-answer controls and independent research processes.

Discuss independent validation →
BIOPHARMA + TRANSLATIONAL RESEARCH

Research use-case collaboration

Explore carefully scoped molecular and translational research workflows and help prioritize capabilities that are valuable in real research programs.

Explore research collaboration →

RESPONSIBLE SCIENTIFIC POSITIONING

Research ambition with an explicit clinical boundary.

AIOTOR Medical Twin is currently offered for research, education and clinical-academic evaluation. It is not presented as a validated diagnostic system or treatment recommendation tool. Any study involving patients or future clinical decision-support, diagnostic or treatment-linked use must proceed under appropriate institutional oversight, ethics review, scientific validation and applicable regulatory requirements.

JOIN THE MEDICAL TWIN RESEARCH NETWORK

Use it academically, or help us validate what comes next.

Universities can discuss institutional subscription and research access. Hospitals, investigators, CROs and validation partners can propose a collaborative study or validation program.